Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABD.L Regulatory News (ABD)

  • There is currently no data for ABD

Update research from QuotedData

9 Nov 2021 13:47

RNS Number : 7962R
Aberdeen New Dawn Invest Trust PLC
09 November 2021
 

Aberdeen New Dawn Investment Trust - Update research from QuotedData

4th November 2021

 

Caution wins out in the end

 

 

After another challenging six months since our last note, with initially unscathed Asia finally being hit hard by COVID-19, Aberdeen New Dawn (ABD) has maintained its strong performance, showing it can still be resilient in falling markets.

 

 

Full research:

https://quoteddata.com/research/aberdeen-dawn-caution-wins-qd/ 

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

 

NB: Marten & Co was paid to produce this note on Aberdeen New Dawn Investment Trust Plc and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the FCA. Marten & Co is not permitted to provide investment advice to individual investors.

 

QUOTEDDATA123a Kings Road | London SW3 4PLTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUKRRRARUARAA
Date   Source Headline
19th Jan 202312:43 pmRNSNet Asset Value(s)
18th Jan 20235:10 pmRNSNet Asset Value(s)
18th Jan 20233:40 pmRNSHolding(s) in Company
18th Jan 202310:50 amRNSPortfolio disclosure
17th Jan 20235:17 pmRNSTransaction in Own Shares
17th Jan 202312:19 pmRNSNet Asset Value(s)
16th Jan 20232:11 pmRNSGearing disclosure
16th Jan 20231:05 pmRNSNet Asset Value(s)
13th Jan 20235:13 pmRNSTransaction in Own Shares
13th Jan 20231:08 pmRNSNet Asset Value(s)
12th Jan 202312:05 pmRNSNet Asset Value(s)
11th Jan 202311:10 amRNSNet Asset Value(s)
10th Jan 20235:23 pmRNSTransaction in Own Shares
10th Jan 202312:01 pmRNSNet Asset Value(s)
9th Jan 20235:18 pmRNSGearing disclosure
9th Jan 202312:12 pmRNSNet Asset Value(s)
6th Jan 20235:21 pmRNSTransaction in Own Shares
6th Jan 20233:03 pmRNSMonth End Net Asset Value(s)
6th Jan 202312:52 pmRNSNet Asset Value(s)
5th Jan 202312:11 pmRNSNet Asset Value(s)
5th Jan 202310:16 amRNSDoc re. Half Yearly Report
4th Jan 202312:22 pmRNSNet Asset Value(s)
3rd Jan 20232:50 pmRNSGearing disclosure
3rd Jan 202310:36 amRNSTotal Voting Rights
30th Dec 202211:53 amRNSNet Asset Value(s)
29th Dec 20221:08 pmRNSNet Asset Value(s)
29th Dec 202212:56 pmRNSGearing disclosure
28th Dec 20225:17 pmRNSTransaction in Own Shares
28th Dec 202211:35 amRNSNet Asset Value(s)
23rd Dec 20221:03 pmRNSTransaction in Own Shares
23rd Dec 202212:18 pmRNSNet Asset Value(s)
22nd Dec 202211:20 amRNSNet Asset Value(s)
21st Dec 20222:58 pmRNSNet Asset Value(s)
20th Dec 20225:07 pmRNSTransaction in Own Shares
20th Dec 202211:38 amRNSNet Asset Value(s)
19th Dec 20223:49 pmRNSGearing disclosure
19th Dec 202212:50 pmRNSNet Asset Value(s)
16th Dec 202212:43 pmRNSNet Asset Value(s)
15th Dec 20225:16 pmRNSTransaction in Own Shares
15th Dec 202211:37 amRNSNet Asset Value(s)
14th Dec 202212:34 pmRNSNet Asset Value(s)
14th Dec 20227:00 amRNSHalf-year Report
13th Dec 202212:54 pmRNSNet Asset Value(s)
12th Dec 20224:58 pmRNSPortfolio disclosure
12th Dec 20221:53 pmRNSGearing disclosure
12th Dec 202212:52 pmRNSNet Asset Value(s)
9th Dec 20225:11 pmRNSTransaction in Own Shares
9th Dec 20223:24 pmRNSHolding(s) in Company
9th Dec 20221:43 pmRNSNet Asset Value(s)
8th Dec 20221:02 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.